Exact Sciences Corp. (EXAS): Price and Financial Metrics
EXAS Price/Volume Stats
| Current price | $54.38 | 52-week high | $72.83 |
| Prev. close | $55.17 | 52-week low | $39.97 |
| Day low | $54.17 | Volume | 2,084,400 |
| Day high | $55.60 | Avg. volume | 2,624,900 |
| 50-day MA | $49.45 | Dividend yield | N/A |
| 200-day MA | $56.12 | Market Cap | 10.26B |
EXAS Stock Price Chart Interactive Chart >
Exact Sciences Corp. (EXAS) Company Bio
Exact Sciences Corp. is a molecular diagnostics company specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer, in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. (Source:Wikipedia)
EXAS Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EXAS Price Returns
| 1-mo | 2.06% |
| 3-mo | 15.55% |
| 6-mo | -12.94% |
| 1-year | 21.74% |
| 3-year | 13.06% |
| 5-year | -37.30% |
| YTD | -3.22% |
| 2024 | -24.05% |
| 2023 | 49.42% |
| 2022 | -36.39% |
| 2021 | -41.26% |
| 2020 | 43.26% |